Literature DB >> 22811773

Screening for cryptococcal antigenemia in anti-retroviral naïve AIDS patients in benin city, Nigeria.

Favour Osazuwa, John Osilume Dirisu, Patrick Evbaguehita Okuonghae, Ose Ugbebor.   

Abstract

OBJECTIVES: Cryptococcus neoformans is the most incriminated fungal pathogen causing meningitis in acquired immune deficiency syndrome (AIDS) patients, and is known to constitute a major cause of deaths in AIDS patients. This study thus aimed to determine the baseline sero-prevalence of Cryptococcus neoformans infection in anti-retroviral naïve (ART-naïve) AIDS patients using the serum Cryptococcal antigen (crag) detection method. Baseline effect of variation in CD4 counts, as well as sex and age with sero-positivity for crag were also determined.
METHODS: This descriptive cross-sectional study included 150 (61 males and 89 females) ART-naïve AIDS patients attending the Human Immunodeficiency Virus clinic (HIV) at the University of Benin Teaching hospital, Benin City, Nigeria, within the period from February 2011- July 2011. Forty (18 males and 22 females) HIV positive outpatients with CD4 counts >200 cells/µl who were ART-naive were recruited and used as controls. The sero-prevalence of crag in the patients and the control group was measured using the cryptococcal antigen latex agglutination system (CALAS) (Meridian Bioscience, Europe) and CD4 counts were measured using flow cytometry (Partec flow cytometer, Germany).
RESULTS: Of the 150 ART-naïve AIDS patients with CD4 counts ≤200 cells/µL; 19 (12.7%) were positive for serum Cryptococcal antigen. ART-naïve AIDS patients with CD4 count ≤50 cells/µl had the highest prevalence of serum crag. Lower CD4 counts were significantly associated with positivity for serum crag (p<0.001). Age and sex had no significant effect on the sero-positivity for serum crag. One (2.5%) of the controls was sero-positive for crag. Thus, serum crag was significantly associated with AIDS but not with HIV (p<0.001).
CONCLUSION: This study uncovers a high prevalence of crag in ART- naïve AIDS patients in Benin City. The prevalence of crag was higher in ART-naïve AIDS patients with lower CD4 counts. There is an urgent need to introduce routine screening for crag in ART- naïve AIDS patients in our locality to reduce the rapid mortality from Cryptococcal meningitis which accounts for a majority of the morbidity factor if undiagnosed during ART therapy.

Entities:  

Keywords:  ART-naïve AIDS patients; CD4 T cell counts; Cryptococcal antigen; Sero-prevalence

Year:  2012        PMID: 22811773      PMCID: PMC3394362          DOI: 10.5001/omj.2012.51

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  22 in total

1.  Incidence and spectrum of AIDS-defining illnesses among persons treated with antiretroviral drugs.

Authors:  S H Michaels; R Clark; P Kissinger
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease.

Authors:  J A Aberg; J Watson; M Segal; L W Chang
Journal:  HIV Clin Trials       Date:  2000 Jul-Aug

3.  Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.

Authors:  David B Meya; Yukari C Manabe; Barbara Castelnuovo; Bethany A Cook; Ali M Elbireer; Andrew Kambugu; Moses R Kamya; Paul R Bohjanen; David R Boulware
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

4.  Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.

Authors:  Constance A Benson; Jonathan E Kaplan; Henry Masur; Alice Pau; King K Holmes
Journal:  MMWR Recomm Rep       Date:  2004-12-17

5.  Manifestations of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome.

Authors:  M L Cameron; J A Bartlett; H A Gallis; H A Waskin
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

6.  Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.

Authors:  Joseph N Jarvis; Graeme Meintjes; Thomas S Harrison
Journal:  J Infect       Date:  2010-03-20       Impact factor: 6.072

Review 7.  Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus.

Authors:  R W Pinner; R A Hajjeh; W G Powderly
Journal:  Clin Infect Dis       Date:  1995-08       Impact factor: 9.079

8.  Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda.

Authors:  M Okongo; D Morgan; B Mayanja; A Ross; J Whitworth
Journal:  Int J Epidemiol       Date:  1998-08       Impact factor: 7.196

9.  Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.

Authors:  B P Currie; A Casadevall
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

10.  Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania.

Authors:  Peter R Kisenge; Alexander T Hawkins; Venance P Maro; John P D McHele; Ndealilia S Swai; Andreas Mueller; Eric R Houpt
Journal:  BMC Infect Dis       Date:  2007-05-10       Impact factor: 3.090

View more
  15 in total

1.  Mycological Profile of Sputum of HIV Positive Patients with Lower Respiratory Tract Infection and its Correlation with CD4+ T Lymphocyte Count.

Authors:  Jyotsna Chandwani; Nitya Vyas; Saroj Hooja; Babita Sharma; Rakesh Maheshwari
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 2.  Asymptomatic cryptococcemia in resource-limited settings.

Authors:  Ana-Claire Meyer; Mark Jacobson
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

3.  Brief Report: Geographical Variation in Prevalence of Cryptococcal Antigenemia Among HIV-Infected, Treatment-Naive Patients in Nigeria: A Multicenter Cross-Sectional Study.

Authors:  Echezona E Ezeanolue; Chidi Nwizu; Gregory S Greene; Olatilewa Amusu; Chinwe Chukwuka; Nicaise Ndembi; Rachel M Smith; Tom Chiller; Jennifer Pharr; Thomas R Kozel
Journal:  J Acquir Immune Defic Syndr       Date:  2016-09-01       Impact factor: 3.731

4.  Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.

Authors:  Rachel M Smith; Tuan Anh Nguyen; Hoang Thi Thanh Ha; Pham Hong Thang; Cao Thuy; Truong Xuan Lien; Hien T Bui; Thai Hung Le; Bruce Struminger; Michelle S McConnell; Robyn Neblett Fanfair; Benjamin J Park; Julie R Harris
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

5.  Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infection.

Authors:  Tariro Azure Makadzange; Admire Hlupeni; Rhoderick Machekano; Kathryn Boyd; Takudzwa Mtisi; Primrose Nyamayaro; Christine Ross; Snighdha Vallabhaneni; Shirish Balachandra; Prosper Chonzi; Chiratidzo Ellen Ndhlovu
Journal:  AIDS       Date:  2021-10-01       Impact factor: 4.632

Review 6.  Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy.

Authors:  David Meya; Radha Rajasingham; Elizabeth Nalintya; Mark Tenforde; Joseph N Jarvis
Journal:  Curr Trop Med Rep       Date:  2015

7.  Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.

Authors:  Souleymane Sawadogo; Boniface Makumbi; Anne Purfield; Christophine Ndjavera; Gram Mutandi; Andrew Maher; Francina Kaindjee-Tjituka; Jonathan E Kaplan; Benjamin J Park; David W Lowrance
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

8.  Prevalence and correlates of cryptococcal antigen positivity among AIDS patients--United States, 1986-2012.

Authors:  Jennie McKenney; Rachel M Smith; Tom M Chiller; Roger Detels; Audrey French; Joseph Margolick; Jeffrey D Klausner
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-07-11       Impact factor: 17.586

9.  Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence.

Authors:  Rita O Oladele; Alani S Akanmu; Augustina O Nwosu; Folasade T Ogunsola; Malcolm D Richardson; David W Denning
Journal:  Open Forum Infect Dis       Date:  2016-03-15       Impact factor: 3.835

10.  Prevalence of cryptococcal antigen positivity among HIV infected patient with CD4 cell count less than 100 of Imam Khomeini Hospital, Tehran, Iran.

Authors:  Mahboobeh Hajiabdolbaghi; Saeed Kalantari; Mahin Jamshidi-Makiani; Esfandiar Shojaei; Ladan Abbasian; Mehrnaz Rasoulinezhad; Katayoun Tayeri
Journal:  Iran J Microbiol       Date:  2017-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.